Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:27
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Tumor infiltrating T cells influence prognosis in stage I-III NSCLC patients
    Schulze, A. B.
    Evers, G.
    Goerlich, D.
    Mohr, M.
    Marra, A.
    Hillejan, L.
    Rehkaemper, J.
    Heitkoetter, B.
    Schmidt, L. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 138 - 138
  • [22] Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients
    Lino-Silva, Leonardo S.
    Anchondo-Nunez, Patricia
    Chit-Huerta, Alonso
    Aguilar-Romero, Estefania
    Morales-Soto, Jonathan
    Salazar-Garcia, Jenny A.
    Guzman-Lopez, Cristina J.
    Maldonado-Martinez, Hector A.
    Meneses-Garcia, Abelardo
    Salcedo-Hernandez, Rosa A.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 300 - 307
  • [23] Single Center Experience with Disseminated Tumor Cells as Predictors of Outcome in Patients with Stage I-III Breast Cancer
    Gainer, S. M.
    Krishnamurthy, S.
    Bhattacharyya, A.
    Lodhi, A.
    Hall, C.
    Bedrosian, I.
    Kuerer, H. M.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S62 - S62
  • [24] Prognostic and predictive value of radiomics signatures in stage I-III colon cancer
    Dai, Weixing
    Mo, Shaobo
    Han, Lingyu
    Xiang, Wenqiang
    Li, Menglei
    Wang, Renjie
    Tong, Tong
    Cai, Guoxiang
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (01): : 288 - 293
  • [25] Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities in Patients with Resected Stage I-III Colon Cancer
    Swords, Douglas S.
    Bednarski, Brian K.
    Messick, Craig A.
    Tillman, Matthew M.
    Chang, George J.
    You, Y. Nancy
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 706 - 716
  • [26] The effects of inpatient exercise therapy on the length of hospital stay in stages I-III colon cancer patients: randomized controlled trial
    Ahn, Ki-Yong
    Hur, Hyuk
    Kim, Dong-Hyun
    Min, Jihee
    Jeong, Duck Hyoun
    Chu, Sang Hui
    Lee, Ji Won
    Ligibel, Jennifer A.
    Meyerhardt, Jeffrey A.
    Jones, Lee W.
    Jeon, Justin Y.
    Kim, Nam Kyu
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (05) : 643 - 651
  • [27] Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer
    Zhao, Zhengyi
    Cai, Shangli
    Wang, Zhijie
    JAMA ONCOLOGY, 2020, 6 (06) : 932 - 932
  • [28] Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
    C-Y Lu
    H-L Tsai
    Y-H Uen
    H-M Hu
    C-W Chen
    T-L Cheng
    S-R Lin
    J-Y Wang
    British Journal of Cancer, 2013, 108 : 791 - 797
  • [29] Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
    Lu, C-Y
    Tsai, H-L
    Uen, Y-H
    Hu, H-M
    Chen, C-W
    Cheng, T-L
    Lin, S-R
    Wang, J-Y
    BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 791 - 797
  • [30] Clinical outcomes of resected EGFR positive stage I-III NSCLC patients in the Midlands, UK
    Powell, R. L.
    Murukesh, N.
    Seeva, P.
    Solanki, A.
    Singh, A.
    Jain, A.
    Elmasry, A. R.
    Jegannathen, A.
    Irwin, A.
    Ghafoor, Q.
    O'Sullivan, B.
    Taniere, P.
    Baijal, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S731 - S732